title: Vancomycin-Resistant Staphylococcus aureus - Delaware, 2015.
abstract: Vancomycin-resistant Staphylococcus aureus (VRSA) is a rare, multidrug-resistant bacterium of public health concern that emerged in the United States in 2002. VRSA (S. aureus with vancomycin minimum inhibitory concentration [MIC] ≥16 μg/mL) arises when vancomycin resistance genes (e.g., the vanA operon, which codes for enzymes that result in modification or elimination of the vancomycin binding site) from vancomycin-resistant enterococci (VRE) are transferred to S. aureus (1). To date, all VRSA strains have arisen from methicillin-resistant S. aureus (MRSA). The fourteenth VRSA isolate (VRSA 14) identified in the United States was reported to CDC in February 2015.
authors.forename: Maroya Spalding
authors.initials: MS
authors.lastname: Walters
authors.forename: Paula
authors.initials: P
authors.lastname: Eggers
authors.forename: Valerie
authors.initials: V
authors.lastname: Albrecht
authors.forename: Tatiana
authors.initials: T
authors.lastname: Travis
authors.forename: David
authors.initials: D
authors.lastname: Lonsway
authors.forename: Greg
authors.initials: G
authors.lastname: Hovan
authors.forename: Debra
authors.initials: D
authors.lastname: Taylor
authors.forename: Kamile
authors.initials: K
authors.lastname: Rasheed
authors.forename: Brandi
authors.initials: B
authors.lastname: Limbago
authors.forename: Alexander
authors.initials: A
authors.lastname: Kallen
mesh_terms: D003691:Delaware; D006801:Humans; D013211:Staphylococcus aureus / Q000187:drug effects*; D014640:Vancomycin / Q000494:pharmacology*; D020713:Vancomycin Resistance
chemical_list: D014640:Vancomycin